Table 2.
Clinical presentation, coronary artery disease, and PCI indications in diabetic-smokers compared with the other 3 groups.
| Clinical variable | Diabetic-smokers | Diabetic-nonsmokers | Nondiabetic-smokers | Nondiabetic-nonsmokers | p value |
|---|---|---|---|---|---|
| Total number | 467 | 833 | 588 | 538 | |
| Presentation: | 0.0001 | ||||
| ACS (n, %) | 380 (81.4%) | 610 (73.2%) | 482 (82%) | 398 (74%) | |
| Stable coronary disease (n, %) | 87 (22.9%) | 223 (26.8%) | 106 (18%) | 140 (26%) | |
| STEMI (n, %) | 165 (35.3%) | 184 (22.1%) | 238 (40.5%) | 139 (25.8%) | 0.0001 |
| NSTEMI (n, %) | 66 (14.13%) | 85 (10.2%) | 92 (15.6%) | 63 (11.7%) | |
| Multivessel CAD (n, %) | 195 (41.8%) | 385 (46.2%) | 211 (35.9%) | 218 (40.5%) | 0.001 |
| Multivessel PCI (n, %) | 128 (27.4%) | 279 (33.5%) | 137 (23.3%) | 144 (26.8%) | 0.018 |
| High GRACE risk score at discharge (highest tertile) | 123 (26.3%) | 353 (42.3%) | 125 (21.3%) | 230 (42.9%) | 0.008 |
| CRUSADE bleeding risk score (highest 2 pentile) | 132 (28.6%) | 533 (63.9%) | 90 (15.3%) | 189 (35.2%) | 0.0001 |
ACS: acute coronary syndrome; CAD: coronary artery disease; GRACE risk score; CRUSADE bleeding risk score; STEMI: ST-segment elevation myocardial infarction.